Table 3.

Clinical and laboratory findings of BAL with KMT2Ar according to the literature review

Pt	Reference	Age (m)	Gender	Involved organs	WBC (× 109/L)	Hb (g/L)	PLT (× 109/L)
1	13	96	F	Spleen	43.9	80	6
2	14	23	F	Liver, renal, CNS	87	75	10
3	15	13	M	Lymph node, spleen	60.1	83	63
4	15	12	F	Lymph node, spleen, liver	31.5	132	261
5	17	11	F	–	6.79	57	57
6	16	4	M	Skin, testicular	33.2	ND	136
7	16	8	F	Liver, spleen, adenopathy, skin	160.9	ND	19
8	18	23	F	Liver, CNS, renal	87	75	10
9	18	16	F	Spleen, CNS	93.4	62	133
10	18	5	M	Renal, skin	96.5	96	80
11	18	13	F	Liver, spleen, lymph node	24	49	10
12	18	8	M	spleen	14.58	64	167
13	19	1.5	F	Liver, spleen	329	ND	ND
14	20	4	M	–	117.2	94	54
15	11	108	M	Spleen	1.8	72	45
16	8	3	M	Liver, spleen and renal	857	88	46
17	8	6	M	Liver, spleen and renal, CNS	119	89	85
18	8	6	M	Splenomegaly, skin	11	72	104
19	8	13	F	Lymph node	39	45	11
20	8	18	F	–	68	3	16
21	12	15	F	Liver, renal, lymph node	54	78	41
22	12	4	F	Liver, spleen	295	29	45
23	12	48	F	liver	209	ND	21
24	9	24	M	liver, spleen, lymph node	425.58	56	57

F, female; M, male; ND, no data